Impact of immunohistochemistry-based molecular subtype on predicting chemotherapy response and survival in patients with T1 stage bladder cancer after bladder-preserving treatment

ConclusionsThe immunohistochemistry-based molecular subtypes could predict the patient ’s prognosis and clinically different chemotherapeutic survival outcomes in patients with T1 stage bladder cancer after bladder-preserving treatment.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research